Literature DB >> 10406649

From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonists.

M J Tozer1, E A Harper, S B Kalindjian, M J Pether, N P Shankley, G F Watt.   

Abstract

Histamine was converted to a selective histamine H3-receptor antagonist by capping the primary amine with 2-naphthalenesulfonyl chloride. Higher receptor affinity and lower variability in the data from the various bioassays were achieved with the 2-naphthalensulfonamides of histamine homologues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406649     DOI: 10.1016/s0960-894x(99)00272-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  N α-arylsulfonyl histamines as selective β-glucosidase inhibitors.

Authors:  M O Salazar; M I Osella; I A Ramallo; R L E Furlan
Journal:  RSC Adv       Date:  2018-10-24       Impact factor: 3.361

2.  Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.

Authors:  Daniele Pala; Laura Scalvini; Alessio Lodola; Marco Mor; Lisa Flammini; Elisabetta Barocelli; Valeria Lucini; Francesco Scaglione; Silvia Bartolucci; Annalida Bedini; Silvia Rivara; Gilberto Spadoni
Journal:  Int J Mol Sci       Date:  2014-09-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.